| dc.contributor.author |
Laisuan W. |
|
| dc.contributor.author |
Wongsa C. |
|
| dc.contributor.author |
Chiewchalermsri C. |
|
| dc.contributor.author |
Thongngarm T. |
|
| dc.contributor.author |
Rerkpattanapipat T. |
|
| dc.contributor.author |
Iamrahong P. |
|
| dc.contributor.author |
Ruangwattanachok C. |
|
| dc.contributor.author |
Nanthapisal S. |
|
| dc.contributor.author |
Sompornrattanaphan M. |
|
| dc.date.accessioned |
2022-03-10T13:17:01Z |
|
| dc.date.available |
2022-03-10T13:17:01Z |
|
| dc.date.issued |
2021 |
|
| dc.identifier.issn |
11786965 |
|
| dc.identifier.other |
2-s2.0-85118542385 |
|
| dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/17413 |
|
| dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118542385&doi=10.2147%2fJAA.S333098&partnerID=40&md5=ea53204c87f5a790f324985731619e81 |
|
| dc.description.abstract |
Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option. © 2021 Laisuan et al. This work is published and licensed by Dove Medical Press Limited. |
|
| dc.language |
en |
|
| dc.subject |
coronavac |
|
| dc.subject |
immunoglobulin G |
|
| dc.subject |
inactivated vaccine |
|
| dc.subject |
adult |
|
| dc.subject |
anaphylaxis |
|
| dc.subject |
Article |
|
| dc.subject |
Burkholderia pseudomallei |
|
| dc.subject |
clinical article |
|
| dc.subject |
complement activation |
|
| dc.subject |
coronavirus disease 2019 |
|
| dc.subject |
drug hypersensitivity |
|
| dc.subject |
fatigue |
|
| dc.subject |
female |
|
| dc.subject |
fever |
|
| dc.subject |
genetic variation |
|
| dc.subject |
headache |
|
| dc.subject |
human |
|
| dc.subject |
intensive care unit |
|
| dc.subject |
middle aged |
|
| dc.subject |
mortality |
|
| dc.subject |
myalgia |
|
| dc.subject |
nose polyp |
|
| dc.subject |
petechia |
|
| dc.subject |
prick test |
|
| dc.subject |
revaccination |
|
| dc.subject |
shellfish allergy |
|
| dc.subject |
treatment outcome |
|
| dc.subject |
vaccination |
|
| dc.title |
Coronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes |
|
| dc.type |
Article |
|
| dc.rights.holder |
Scopus |
|
| dc.identifier.bibliograpycitation |
Journal of Asthma and Allergy. Vol 14, No. (2021), p.1209-1215 |
|
| dc.identifier.doi |
10.2147/JAA.S333098 |
|